Liquid Biopsy Market Analysis, Size, Share, and Forecast 2031
The Liquid Biopsy Market in 2023 is US$ 5.1 billion, and is expected to reach US$ 19.84 billion by 2031 at a CAGR of 18.52%.
FutureWise Research published a report that analyzes Liquid Biopsy Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.
Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Liquid Biopsy research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.
Request a Sample Report @ Request for Liquid Biopsy Market Sample
Liquid Biopsy Market Segmentation:
By Product
· Assays Kits
· Instruments
· Services
By Circulating Biomarker
· Circulating Tumor Cells (CTCs)
· Circulating Tumor DNA (ctDNA)
· Cell-Free DNA (cfDNA)
· Extracellular Vesicles (EVs)
· Other Circulating Biomarkers
By Clinical Application
· Early Cancer Screening
· Therapy Selection
· Treatment Monitoring
· Recurrence Monitoring Orthopedics
By Application
· Oncology
· Lung Cancer
· Breast Cancer
· Colorectal Cancer
· Prostate Cancer
· Melanoma Cancer
· Other Cancers
· Non-Cancer Application
By End User
· Reference Laboratories
· Hospitals and Physician Laboratories
· Academic and Research Centers
· Other End Users
By Region
· North America
· Latin America
· Europe
· Asia Pacific
· Rest of the World
Major players included in the Liquid Biopsy Market:
· Biocept Inc.
· Qiagen N.V.
· Roche Diagnostics.
· Bio-Rad Laboratories, Inc.
· Myriad Genetics, Inc.
· Menarini-Silicon Biosystems.
· Trovagene Inc.
· Guardant Health, Inc.
· Mdxhealth SA.
· Genomic Health Inc.
Please visit full report of the Liquid Biopsy market @ Visit Liquid Biopsy Market
Competitive Landscape:
· Tier one players - market players with a significant share of the market
· Tier two players
· Players with rapid growth
· New Entries
FutureWise Key Takeaways:
• Prospects for growth
• Analysis of SWOT
• Key trends
• Key Data-points affecting market growth
Objectives of the Study:
• To provide report with an in-depth analysis of the Liquid Biopsy Market By Product, By Circulating Biomarker, By Clinical Application, By Application, By End User and By Region
• To offer data-points and comprehensive data on factors affecting the market (Opportunities, drivers, and industry-specific restraints)
• Analysis and forecasting of micro-markets, as well as the scope of the market.
• To predict the size and share, market forecast, in key regions — North America, Europe, Asia Pacific, and rest of the world
• To record and evaluate competition -mergers and expansions, product launches, and technological advancements within the market
Flexible Delivery Model:
• With our flexible delivery model, you will be able to suggest changes within the scope/table of content based on your requirement.
• Customization services are included with the purchase of any license type of report.
• Customization requests can be sent directly to: sales@futurewiseresearch.com
FutureWise Research:
Contact Person: Vinay T.
Email: sales@futurewiseresearch.com
Contact Number: UK: +44 1416289353 | US: +1 3477094931
Website: www.futurewiseresearch.com
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian